Gastro Inflammation Research Formula

Gastro Inflammation Research Formula combines the peptides BPC-157, KPV, and N-Acetyl Larazotide, each contributing to its anti-inflammatory properties by modulating immune responses and enhancing gut barrier integrity. Interest in Gastro Inflammation Research Formula started around the early 2000s when researchers explored its potential in managing gastrointestinal inflammation and related disorders. BPC-157, a peptide derived from human gastric juice, is known for its role in tissue repair and angiogenesis. Meanwhile, KPV acts by influencing the melanocortin system, and N-Acetyl Larazotide aims to tighten the intestinal barrier by regulating tight junctions. This formula is particularly intriguing due to its multi-faceted approach to inflammation control and mucosal protection. Today, it is primarily studied for its effects on:

• Gastrointestinal inflammation
• Gut barrier function
• Immune modulation
• Tissue repair
• Angiogenesis

Recent studies have also focused on the potential of these peptides to address systemic inflammatory responses beyond the gut.

PeptideSource editorial · Updated Jul 18, 2026